Tag: Q2 FY27 Results
GENERAL Supriya Lifescience Q2 PAT Falls 42% To ₹29.25 Cr On High Operating Costs

Supriya Lifescience Ltd reported a 42% year-on-year decline in consolidated profit after tax (PAT) to ₹29.25 crore for the second quarter of FY27, compared with ₹50.43 crore in the corresponding quarter of the previous financial year, as higher operating costs, product mix changes and elevated raw material prices weighed on margins. Revenue from operations, however, […]

CW Bureau · Nov 6, 2026
BANKING & FINANCE Sundaram Finance Chairman S Viji Resigns; R Venkatraman Succeeds

Sundaram Finance Ltd, a leading Non-Banking Financial Company, has announced that S Viji has relinquished his position as Non-Executive Director and Chairman of the Board with effect from November 4, 2026, citing age and personal considerations. The Board has elected Independent Director R Venkatraman as the new Chairman. Viji served on the company’s Board for […]

CW Bureau · Nov 5, 2026